BOCA RATON, Fla. - nvtip -- Suthe is proud to announce the launch of its new website, SutheDermal.com, introducing DigiVibe™—a groundbreaking device designed to alleviate the discomfort and anxiety associated with self-injections and finger pricking.

With the rising prevalence of injectable treatments for conditions like diabetes, fertility protocols & weight management, SutheDermal.com addresses a critical need for a more comfortable patient experience. DigiVibe™ employs advanced vibration technology to minimize pain perception, making self-injection more manageable for users.

More on nvtip.com

• Perspectives: Jellyfish Publication of an exciting new human clinical trial of proprietary KollaJell™ collagen peptide formulation
• Las Vegas Realtor Nancy Ruiz Earns Certified Luxury Home Marketing Specialist™ Designation
• Sequentex Achieves OMNIA Partners Approval, Empowering Public Sector and other Agencies with Streamlined Technology Procurement
• CEO Selected to Present at Wall Street Conference on May 21, 2025 for Suicidal Depression / PTSD: NRx Pharmaceuticals, Inc. (Stock Symbol: NRXP)
• $10 Million Plan to Acquire Successful Remote Lottery Platform: Expanding Global Footprint into Live Entertainment: Lottery.com (Stock Symbol: LTRY)

The newly launched website offers:

• User-Centric Design: An intuitive interface that guides users through product information and purchasing options.
• Educational Resources: Comprehensive guides and FAQs to assist users in understanding and utilizing DigiVibe™ effectively.
• Secure E-Commerce Platform: A streamlined shopping experience with robust security measures to protect customer information.  

"Our mission is to enhance the quality of life for individuals requiring regular injections by providing innovative solutions that reduce discomfort and anxiety," said Mark Lorberbaum, Founder & CEO at Suthe.

For more information, visit https://suthedermal.com.